Medicaid and CHIP Drug Rebate Proposals in the Biden Administration’s Fiscal Year 2024 Budget

Under the highly effective Medicaid Drug Rebate Program (MDRP), drug manufacturers must provide substantial rebates to the federal government and states as a condition of having their drugs covered by Medicaid.  For brand-name drugs, the rebates apply to  both fee-for-service and Medicaid managed care and consist of two mandatory components.  First, under a basic rebate, […]

Medicaid Managed Care: The President’s FY 2024 Budget

President Biden’s FY 2024 Budget includes a number of provisions relating to Medicaid and the Children’s Health Insurance Program (CHIP).  Two of these would improve Medicaid managed care.  One involves recovery of overpayments to managed care organizations (MCOs); the other, a new tool for enforcing MCO compliance with federal rules.  Judging from the lack of […]